# Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial

Study · id `cardio:ct-nct06949228` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06949228](<https://clinicaltrials.gov/study/NCT06949228>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06949228

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 132 participants.

## Technical summary

Registry record NCT06949228. Randomized; no masking; primary purpose treatment. Start 2025-07-30 (actual); primary completion 2028-05-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 132 participants (planned count; ClinicalTrials.gov record NCT06949228, source copy `cardio:ctgov-nct06949228-2026-01-21`, retrieved 2026-10-26)
- Started: 2025-07-30 (actual) (ClinicalTrials.gov record NCT06949228, source copy `cardio:ctgov-nct06949228-2026-01-21`, retrieved 2026-10-26)
- Primary completion: 2028-05-30 (anticipated) (ClinicalTrials.gov record NCT06949228, source copy `cardio:ctgov-nct06949228-2026-01-21`, retrieved 2026-10-26)
- Completion: 2028-05-30 (anticipated) (ClinicalTrials.gov record NCT06949228, source copy `cardio:ctgov-nct06949228-2026-01-21`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06949228, source copy `cardio:ctgov-nct06949228-2026-01-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06949228-2026-01-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
- Acronym: ALLY II TNK
- Condition: Ischemic Stroke
- Condition: Acute Disease
- Intervention (Drug): tenecteplase
- Lead sponsor: ProMedica Health System
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention is a member of this class by a sourced record link: Fibrinolytic (clot-dissolving) drugs (`cardio:fibrinolytic-clot-dissolving-drugs`)

## Provenance

Content hash: 82bc8ef356e9898fa226e66b7107a37b3b5145ba2ab38d92f40e53106b28523b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
